文献速递遗传性与小管间质肾病慢性肾脏病

常染色体显性APOA4突变表现为肾小管间质肾病伴髓质淀粉样变

Autosomal dominant ApoA4 mutations present as tubulointerstitial kidney disease with medullary amyloidosis.
PubMed 文献 · Kidney Int · 2023-12-12

本研究在五个家系中发现两种不同的致病性APOA4变异(p.L66V和p.D33N)导致常染色体显性髓质淀粉样变。患者表现为慢性肾脏病伴尿沉渣无异常,平均肾衰竭年龄64.5岁,肾脏病理显示淀粉样沉积局限于肾髓质,质谱鉴定突变ApoA4为主要淀粉样成分。诊断依赖详细家族史、APOA4测序和病理研究。

要点

  • APOA4突变可导致常染色体显性遗传的肾髓质淀粉样变,表现为慢性肾脏病伴尿沉渣无异常。
  • 两种变异p.L66V和p.D33N均位于进化保守区域,预测扩展ApoA4淀粉样热点。
  • 诊断需结合家族史、APOA4基因测序及肾组织病理学检查(质谱鉴定淀粉样成分)。

核心结论

  • APOA4突变可导致常染色体显性髓质淀粉样变,淀粉样沉积局限于肾髓质,临床表现为常染色体显性慢性肾脏病伴尿沉渣无异常。

研究设计与样本

  • 研究描述了五个家系,发现两种不同的致病性APOA4变异(p.L66V和p.D33N),通过全基因组测序和家系登记识别。

主要发现

  • 临床受累个体表现为慢性肾脏病伴尿沉渣无异常,平均肾衰竭年龄为64.5岁。
  • 基因分型 identified 48例遗传受累个体,其中44例eGFR低于60 ml/min/1.73 m2,包括全部25例肾衰竭个体;14例遗传未受累个体中11例eGFR高于60 ml/min/1.73 m2。
  • 四例个体的肾脏病理标本显示淀粉样沉积局限于髓质,三例可用活检中质谱鉴定突变ApoA4为主要淀粉样成分。

关键数值与推荐

  • 两种变异均为受累家系独有、进化保守,并预测扩展ApoA4结构中的淀粉样热点。
  • 基因型-表型关联:48例遗传受累个体中44例eGFR低于60 ml/min/1.73 m2,14例遗传未受累个体中11例eGFR高于60 ml/min/1.73 m2。

临床怎么用

  • 对于常染色体显性慢性肾脏病伴尿沉渣无异常的患者,应考虑APOA4相关髓质淀粉样变,诊断依赖详细家族史、APOA4测序和病理研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sporadic cases of apolipoprotein A-IV medullary amyloidosis have been reported. Here we describe five families found to have autosomal dominant medullary amyloidosis due to two different pathogenic APOA4 variants. A large family with autosomal dominant chronic kidney disease (CKD) and bland urinary sediment underwent whole genome sequencing with identification of a chr11:116692578 G>C (hg19) variant encoding the missense mutation p.L66V of the ApoA4 protein. We identified two other distantly related families from our registry with the same variant and two other distantly related families with a chr11:116693454 C>T (hg19) variant encoding the missense mutation p.D33N. Both mutations are unique to affected families, evolutionarily conserved and predicted to expand the amyloidogenic hotspot in the ApoA4 structure. Clinically affected individuals suffered from CKD with a bland urinary sediment and a mean age for kidney failure of 64.5 years. Genotyping identified 48 genetically affected individuals; 44 individuals had an estimated glomerular filtration rate (eGFR) under 60 ml/min/1.73 m2, including all 25 individuals with kidney failure. Significantly, 11 of 14 genetically unaffected individuals had an eGFR over 60 ml/min/1.73 m2. Fifteen genetically affected individuals presented with higher plasma ApoA4 concentrations. Kidney pathologic specimens from four individuals revealed amyloid deposits limited to the medulla, with the mutated ApoA4 identified by mass-spectrometry as the predominant amyloid constituent in all three available biopsies. Thus, ApoA4 mutations can cause autosomal dominant medullary amyloidosis, with marked amyloid deposition limited to the kidney medulla and presenting with autosomal dominant CKD with a bland urinary sediment. Diagnosis relies on a careful family history, APOA4 sequencing and pathologic studies.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Kmochová T, Kidd KO, Orr A, et al. Autosomal dominant ApoA4 mutations present as tubulointerstitial kidney disease with medullary amyloidosis. Kidney Int. 2023. PMID: 38096951. doi:10.1016/j.kint.2023.11.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。